Related Articles
Clinical significance of androgen receptor expression in triple negative breast cancer‑an immunohistochemistry study
Cyclooxygenase‑2 expression in non‑metastatic triple‑negative breast cancer patients
Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
Expression and prognostic value of estrogen receptor β in patients with triple-negative and triple-positive breast cancer
Precision medicine based on tumorigenic signaling pathways for triple‑negative breast cancer (Review)